CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Magnetic-Acoustic Sequentially Actuated CAR T Cell Microrobots for Precision Navigation and In Situ Antitumor Immunoactivation.
Magnetic-Acoustic Sequentially Actuated CAR T Cell Microrobots for Precision Navigation and In Situ Antitumor Immunoactivation.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
尽管CAR-T 细胞免疫疗法在临床上已取得成功,但实体瘤中的疗效仍受严峻物理屏障和免疫抑制性微环境限制。本研究通过点击偶联将免疫磁珠装饰于CAR-T 细胞表面,构建基于CAR-T 细胞的活体微型机器人(M-CAR-T)。M-CAR-T 可由磁场和声场驱动,实现精准靶向并在原位激活抗肿瘤免疫反应。顺序驱动赋予M-CAR-T 磁控抗流和避障能力,并可借助声推进穿透组织,使其在人工肿瘤模型中高效迁移、聚集。在体内,可通过程序化磁场引导顺序驱动的M-CAR-T 进行长距离靶向并聚集于肿瘤周边区域,随后利用声镊驱动其进入深部肿瘤组织;与未驱动的情况相比,外源性CD8⁺ CAR-T 细胞的聚集量增加6.6倍。抗CD3/CD28免疫磁珠可刺激浸润的CAR-T 细胞在原位增殖和活化,显著增强抗肿瘤效力。
因此,这种顺序驱动引导的细胞微型机器人兼具智能机器人的自主靶向和组织穿透优势,以及T细胞原位免疫激活能力,有望用于精准导航和癌症免疫治疗。
Despite its clinical success, chimeric antigen receptor T (CAR T)-cell immunotherapy remains limited in solid tumors, owing to the harsh physical barriers and immunosuppressive microenvironment.
Here a CAR-T-cell-based live microrobot (M-CAR T) is created by decorating CAR T with immunomagnetic beads using click conjugation. M-CAR Ts are capable of magnetic-acoustic actuation for precision targeting and in situ activation of antitumor immune responses. Sequential actuation endows M-CAR Ts with magnetically actuated anti-flow and obstacle avoidance as well as tissue penetration driven by acoustic propulsion, enabling efficient migration and accumulation in artificial tumor models.
In vivo, sequentially actuated M-CAR Ts achieves long-distance targeting and accumulate at the peritumoural area under programmable magnetic guidance, and subsequently acoustic tweezers actuate M-CAR Ts to migrate into deep tumor tissues, resulting in a 6. 6-fold increase in accumulated exogenous CD8 + CAR T cells compared with that without actuation. Anti-CD3/CD28 immunomagnetic beads stimulate infiltrated CAR T proliferation and activation in situ, significantly enhancing their antitumor efficacy.
Thus, this sequential-actuation-guided cell microrobot combines the merits of autonomous targeting and penetration of intelligent robots with in situ T-cell immunoactivation, and holds considerable promise for precision navigation and cancer immunotherapies.
MEMBER ACCOUNT
登录成功会直接打开下一页。